Old Web
English
Sign In
Acemap
>
Paper
>
926TiPNeo-adjuvant ipilimumab and nivolumab in high risk resectable bladder urothelial cancer (NABUCCO)
926TiPNeo-adjuvant ipilimumab and nivolumab in high risk resectable bladder urothelial cancer (NABUCCO)
2018
N. van Dijk
Christian U. Blank
Pia Kvistborg
Ton N. M. Schumacher
E Hooijberg
Karolina Sikorska
Bas W.G. van Rhijn
M. van der Heijden
Keywords:
General surgery
Nivolumab
Medicine
Ipilimumab
Adjuvant
Cancer
Cancer research
Internal medicine
urothelial cancer
Oncology
neo adjuvant
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]